Rhian E Davies1, Jeremy D Rier2. 1. Division of Cardiology, Brown University, Providence, USA. 2. Department of Cardiology, WellSpan Cardiology, 755 Norman Drive, Lebanon, PA, 17042, USA. jrier@wellspan.org.
Abstract
PURPOSE OF REVIEW: The goal of this article is to review the disparities that exist for women who present for treatment of ischemic heart disease. RECENT FINDINGS: It is well known that women are more likely to present with ischemic heart disease at an advanced age with more comorbidities when compared to male counterparts. Despite correction of risk factors, women experience worse outcomes, even in the absence of obstructive coronary artery disease. A review of the literature highlights the importance of a thoughtful approach to medical therapy and revascularization. While most recommendations applied to women are derived mostly from male data, further study of sex-specific differences may lead to approaches which can ultimately reduce disparities for the treatment of ischemic heart disease in women.
PURPOSE OF REVIEW: The goal of this article is to review the disparities that exist for women who present for treatment of ischemic heart disease. RECENT FINDINGS: It is well known that women are more likely to present with ischemic heart disease at an advanced age with more comorbidities when compared to male counterparts. Despite correction of risk factors, women experience worse outcomes, even in the absence of obstructive coronary artery disease. A review of the literature highlights the importance of a thoughtful approach to medical therapy and revascularization. While most recommendations applied to women are derived mostly from male data, further study of sex-specific differences may lead to approaches which can ultimately reduce disparities for the treatment of ischemic heart disease in women.
Entities:
Keywords:
Acute coronary syndrome; Gender disparities; Ischemic heart disease; Women
Authors: Sherita Hill Golden; Arleen Brown; Jane A Cauley; Marshall H Chin; Tiffany L Gary-Webb; Catherine Kim; Julie Ann Sosa; Anne E Sumner; Blair Anton Journal: J Clin Endocrinol Metab Date: 2012-06-22 Impact factor: 5.958
Authors: Andra L Blomkalns; Anita Y Chen; Judith S Hochman; Eric D Peterson; Kelly Trynosky; Deborah B Diercks; Gerard X Brogan; William E Boden; Matthew T Roe; E Magnus Ohman; W Brian Gibler; L Kristin Newby Journal: J Am Coll Cardiol Date: 2005-03-15 Impact factor: 24.094
Authors: T C Clayton; S J Pocock; R A Henderson; P A Poole-Wilson; T R D Shaw; R Knight; K A A Fox Journal: Eur Heart J Date: 2004-09 Impact factor: 29.983
Authors: S Dey; M D Flather; G Devlin; D Brieger; E P Gurfinkel; P G Steg; G Fitzgerald; E A Jackson; K A Eagle Journal: Heart Date: 2008-05-07 Impact factor: 5.994
Authors: Andres Alejandro Kohan; Ezequiel Levy Yeyati; Luciano De Stefano; Laura Dragonetti; Marcelo Pietrani; Diego Perez de Arenaza; Cesar Belziti; Ricardo Daniel García-Mónaco Journal: Cardiovasc Diagn Ther Date: 2014-04
Authors: Choongki Kim; Hyuk-Jae Chang; Iksung Cho; Ji Min Sung; Donghoon Choi; Myung Ho Jeong; Yang Soo Jang Journal: Korean J Intern Med Date: 2013-08-14 Impact factor: 2.884
Authors: Ziad Faramand; Mohammad Alrawashdeh; Stephanie Helman; Zeineb Bouzid; Christian Martin-Gill; Clifton Callaway; Salah Al-Zaiti Journal: Res Nurs Health Date: 2021-11-24 Impact factor: 2.228